D-0684-2018 Class II Terminated
FDA drug recall D-0684-2018 was initiated by Lupin Pharmaceuticals Inc. on Mar 27, 2018 and is designated Class II. Reason for recall: Superpotent Drug The recall status is terminated (terminated Apr 15, 2019). Affected quantity: 40,824 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 25, 2018
- Initiation Date
- Mar 27, 2018
- Termination Date
- Apr 15, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,824 bottles
Product Description
Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202
Reason for Recall
Superpotent Drug
Distribution Pattern
Nationwide
Code Information
Lot # F602241; Exp. 10/18 Lot # F602577; Exp. 11/18 Lot # F700036; Exp. 12/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0684-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026